Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19
Authors
Keywords
-
Journal
JAMA Network Open
Volume 4, Issue 4, Pages e216468
Publisher
American Medical Association (AMA)
Online
2021-04-23
DOI
10.1001/jamanetworkopen.2021.6468
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- An Overview of Platform Trials with a Checklist for Clinical Readers
- (2020) Jay J.H. Park et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories
- (2020) Joshua A. Lieberman et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Early Detection of Covid-19 through a Citywide Pandemic Surveillance Platform
- (2020) Helen Y. Chu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
- (2020) Caleb P. Skipper et al. ANNALS OF INTERNAL MEDICINE
- Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence
- (2020) Myron S. Cohen NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
- (2020) Munyaradzi Dimairo et al. Trials
- Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review
- (2020) Jennifer Santos et al. Viruses-Basel
- The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
- (2020) Munyaradzi Dimairo et al. BMJ-British Medical Journal
- Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19
- (2020) Craig R. Rayner et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
- (2020) Sherief Abd-Elsalam et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2020) Peter W Horby et al. LANCET
- Clinical trials of disease stages in COVID 19: complicated and often misinterpreted
- (2020) Jay J H Park et al. Lancet Global Health
- Early Treatment of COVID-19 Disease: A Missed Opportunity
- (2020) Jamie I. Forrest et al. Infectious Diseases and Therapy
- The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19
- (2020) Zelyn Lee et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols
- (2019) Jay J. H Park et al. Trials
- Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI)
- (2018) John H. Powers et al. PLoS One
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
- (2017) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficiencies of platform clinical trials: A vision of the future
- (2016) Benjamin R Saville et al. Clinical Trials
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
- (2015) Jasper Fuk-Woo Chan et al. JOURNAL OF INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started